Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation.

2010

Study identifies mechanisms that impact the efficacy of EGFR inhibitors in drug resistant lung cancer cells.

Keywords:

References

163

Citations